Clinical Trials

Can mRNA Vaccines Revolutionize Treatment for EBV-Related Tumors?
Research & Development Can mRNA Vaccines Revolutionize Treatment for EBV-Related Tumors?

A groundbreaking advancement in tumor immunotherapy is unfolding with the approval of a new mRNA vaccine for Epstein-Barr virus (EBV) positive tumors by China's National Medical Products Administration (NMPA) for Phase-I clinical trials. Developed independently by WestGene Biopharma Co., Ltd.,

Pfizer Shows Promising Results for RSV Vaccine in Immunocompromised Adults
Research & Development Pfizer Shows Promising Results for RSV Vaccine in Immunocompromised Adults

Pfizer Inc. has unveiled a significant advancement in their ongoing Phase 3 MONeT trial, specifically through a substudy aiming to evaluate the efficacy and safety of its RSV vaccine, ABRYSVO, in immunocompromised adults. Historically, this vulnerable population has faced severe complications from

How Is Data Analytics Revolutionizing the Pharmaceutical Industry?
Tech & Innovation How Is Data Analytics Revolutionizing the Pharmaceutical Industry?

The pharmaceutical industry is undergoing a significant transformation driven by the integration of data analytics, reshaping various aspects such as drug discovery, clinical trials, supply chain management, and commercial strategies. This change is not just a trend but a necessity as the industry

How Is Pharma Analytics Transforming Drug Development and Compliance?
Tech & Innovation How Is Pharma Analytics Transforming Drug Development and Compliance?

The pharmaceutical industry is undergoing a significant transformation driven by the advent of pharma analytics. Utilizing modern data analytics tools has revolutionized various stages of drug development, manufacturing, and distribution. This article explores how these advancements are shaping the

FDA Approves Tecelra, Pioneering Cell Therapy for Synovial Sarcoma
Research & Development FDA Approves Tecelra, Pioneering Cell Therapy for Synovial Sarcoma

The U.S. Food and Drug Administration (FDA) has ushered in a new era in cancer treatment with the approval of Tecelra (afamitresgene autoleucel), an innovative therapy aimed at combating synovial sarcoma. This rare and aggressive form of cancer predominantly impacts young adults and has

Red Queen Therapeutics Raises $55M to Tackle Diverse Viral Threats
Research & Development Red Queen Therapeutics Raises $55M to Tackle Diverse Viral Threats

The biotech landscape is abuzz with the launch of Red Queen Therapeutics, a startup that aims to revolutionize antiviral treatments. Backed by a $55 million investment from venture firm Apple Tree Partners and additional funding from the Biomedical Advanced Research and Development Authority

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later